Checkpoint inhibitors, fertility, pregnancy, and sexual life: a systematic review

Immune checkpoint inhibitors (i.e. anti-PD1, anti-PDL1, and anti-CTLA4) have revolutionized the therapeutic approach of several cancer types. In a subset of metastatic patients, the duration of the response is so long that a cure might be hypothesized, and a treatment discontinuation strategy could...

Descripción completa

Detalles Bibliográficos
Autores principales: Garutti, M., Lambertini, M., Puglisi, F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487000/
https://www.ncbi.nlm.nih.gov/pubmed/34597942
http://dx.doi.org/10.1016/j.esmoop.2021.100276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8487000/
https://www.ncbi.nlm.nih.gov/pubmed/34597942
http://dx.doi.org/10.1016/j.esmoop.2021.100276

Ejemplares similares